| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $41.8M | +57.9% |
| SG&A Expense | $29.9M | +12.2% |
| Operating Income | -$71.7M | -35.0% |
| Pre-tax Income | -$75.4M | -27.8% |
| Income Tax | $3K | +0.0% |
| Net Income | -$75.4M | -27.8% |
| EPS (Basic) | -$4.06 | -1591.7% |
| EPS (Diluted) | -$4.06 | -1591.7% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.9M | -36.2% |
| Current Assets | $27.4M | -11.5% |
| Total Assets | $28.8M | -10.8% |
| Current Liabilities | $42.6M | -8.9% |
| Total Liabilities | $101.9M | +118.0% |
| Stockholders' Equity | -$73.1M | -406.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.8M | -60.1% |
| Financing Cash Flow | $60.3M | +23.2% |